Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes

被引:15
|
作者
Niwa, T
Shiraga, T
Hashimoto, T
Kagayama, A
机构
[1] Fujisawa Pharmaceut Co Ltd, Biopharmaceut & Pharmacokinet Res Labs, Yodogawa Ku, Osaka 5328514, Japan
[2] Fujisawa Pharmaceut Co Ltd, Postmarketing Dev Res Ctr, Chuo Ku, Osaka 5418514, Japan
关键词
cefixime; cefdinir; human hepatic cytochrome P450; oral cephalosporin; drug interaction;
D O I
10.1248/bpb.27.97
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of two kinds of oral cephalosporins, cefixime and cefdinir, on cytochrome P450 (CYP) activities in human hepatic microsomes were investigated. Both cefixime and cefdinir at 2 mm concentration neither inhibited nor stimulated CYP1A1/2-mediated 7-ethoxyresorufin O-deethylation, CYP2A6-mediated coumarin 7-hydroxylation, CYP2B6-mediated 7-benzyloxyresorufin O-debenzylation, CYP2C8/9-mediated tolbutamide methylhydroxylation, CYP2C19-mediated S-mephenytoin 4'-hydroxylation, CYP2D6-mediated bufuralol 1-hydroxylation, CYP2E1-mediated chlorzoxazone 6-hydroxylation, CYP3A4-mediated nifedipine oxidation, or CYP3A4-mediated testosterone 6beta-hydroxylation. The free fractions of cefixime and cefdinir in the incubation mixture, which were measured by ultracentrifugation, were 86.1-93.8% and 94.1-97.8%, respectively. These results suggest that both cefixime and cefdinir would not cause clinically significant interactions with other drugs, which are metabolized by CYPs, via the inhibition of metabolism.
引用
收藏
页码:97 / 99
页数:3
相关论文
共 50 条
  • [21] Inhibitory Effect of Selaginellins from Selaginella tamariscina (Beauv.) Spring against Cytochrome P450 and Uridine 5′-Diphosphoglucuronosyltransferase Isoforms on Human Liver Microsomes
    Heo, Jae-Kyung
    Phi-Hung Nguyen
    Kim, Won Cheol
    Nguyen Minh Phuc
    Liu, Kwang-Hyeon
    MOLECULES, 2017, 22 (10)
  • [22] Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography-tandem mass spectrometry
    Kim, Hyun-Ji
    Lee, Hyunyoung
    Ji, Hyeon-Kyeong
    Lee, Taeho
    Liu, Kwang-Hyeon
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2019, 40 (3-4) : 101 - 111
  • [23] Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450
    Chiangsom, Abhiruj
    Lawanprasert, Somsong
    Oda, Shingo
    Kulthong, Kornphimol
    Luechapudiporn, Rataya
    Yokoi, Tsuyoshi
    Maniratanachote, Rawiwan
    DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (03) : 210 - 217
  • [24] Effect of pyrantel and dimethoate administration on rat liver cytochrome P450 system
    Wiaderkiewicz, Ryszard
    Zasadowski, Arkadiusz
    Czekaj, Piotr
    Wiaderkiewicz, Anna
    Czajkowska, Beata
    Barski, Dariusz
    Palasz, Artur
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2006, 50 (02) : 253 - 257
  • [25] Drug-drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes
    Kanayama, N.
    Kanari, C.
    Masuda, Y.
    Ohmori, S.
    Ooie, T.
    XENOBIOTICA, 2007, 37 (02) : 139 - 154
  • [26] Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans
    Okudaira, Toshiaki
    Kotegawa, Tsutomu
    Imai, Hiromitsu
    Tsutsumi, Kimiko
    Nakano, Shigeyuki
    Ohashi, Kyoichi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (07): : 871 - 876
  • [27] Involvement of multiple cytochrome P450 isoenzymes in drug interactions between ritonavir and direct oral anticoagulants
    Tamemoto, Yuta
    Shibata, Yukihiro
    Hashimoto, Natsumi
    Sato, Hiromi
    Hisaka, Akihiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 53
  • [28] Effect of eugenol on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activity in human liver microsomes
    Alharbi, Naif Fahad M.
    Ahad, Abdul
    Bin Jardan, Yousef A.
    Al-Jenoobi, Fahad I.
    SAUDI PHARMACEUTICAL JOURNAL, 2024, 32 (07)
  • [29] In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Gentiopicroside: Potent Effect on CYP2A6
    Deng, Yating
    Wang, Lu
    Yang, Yong
    Sun, Wenji
    Xie, Renming
    Liu, Xueying
    Wang, Qingwei
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (04) : 339 - 344
  • [30] Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles
    Yamazaki, Hiroshi
    Nakamoto, Minako
    Shimizu, Makiko
    Murayama, Norie
    Niwa, Toshiro
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (06) : 593 - 597